Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Bone Marrow Transplantation
|
May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant
Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant
Issa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Blood
|
May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
Issa F Khouri, Rima M Saliba, William D Erwin, et al.
JCO Oncology Practice
|
January 10, 2023
Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant
An Ngo-Huang, Rachel Ombres, Rima M Saliba, et al.
Journal for Immunotherapy of Cancer
|
February 27, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
Chantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, et al.
Transplantation and Cellular Therapy
|
September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation
Nicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances
|
August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
Uday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Nature Reviews. Clinical Oncology
|
February 20, 2021
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan, Sajad J Khazal, Hisham Abdel-Azim, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Bone Marrow Transplantation
|
May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant
Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant
Issa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Blood
|
May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
Issa F Khouri, Rima M Saliba, William D Erwin, et al.
JCO Oncology Practice
|
January 10, 2023
Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant
An Ngo-Huang, Rachel Ombres, Rima M Saliba, et al.
Journal for Immunotherapy of Cancer
|
February 27, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
Chantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, et al.
Transplantation and Cellular Therapy
|
September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation
Nicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances
|
August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
Uday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Nature Reviews. Clinical Oncology
|
February 20, 2021
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan, Sajad J Khazal, Hisham Abdel-Azim, et al.
Page
of 3